Literature DB >> 16765005

Management of a severe forceful breather with Rett syndrome using carbogen.

Eric E J Smeets1, Peter O O Julu, Dick van Waardenburg, Ingegerd Witt Engerström, Stig Hansen, Flora Apartopoulos, Leopold M G Curfs, Connie T R M Schrander-Stumpel.   

Abstract

We have used a novel neurophysiological technique in the NeuroScope system in combination with conventional electroencephalography (EEG) to monitor both brainstem and cortical activity simultaneously in real-time in a girl with Rett syndrome. The presenting clinical features in our patient were severe sleep disturbances, irregular breathing in the awake state dominated by Valsalva's type of breathing followed by tachypnoea and very frequent attacks of seizures and vacant spells. Our novel neurophysiological data showed that the patient was a Forceful Breather according to the breathing categories in Rett syndrome. She had frequent abnormal spontaneous brainstem activation (ASBA) preceded by severe attacks of hypocapnoea, which was caused by a combination of Valsalva's type of breathing and tachypnoea and all these together were responsible for the seizures and non-epileptic vacant spells. The ASBA was not detectable in conventional EEG and there were no epileptiform changes in the EEG during the seizures and vacant spells caused by the hypocapnic attacks, therefore these were pseudo-seizures. The record of brainstem activity confirmed that these were autonomic events, a kind of "brainstem epilepsy". We successfully treated the sleep disturbance with Pipamperone, a 5-hydroxytryptophan antagonist of receptor type 2 and we prevented the severe hypocapnoea during Valsalva's type of breathing and during tachypnoea using carbogen (a mixture of 5% carbon dioxide and 95% oxygen), which we gave by inhalation. Our treatment drastically reduced the autonomic events, promoted whole night sleep and significantly improved the quality of life in our patient. She can now participate in normal family activity which was previously impossible before treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16765005     DOI: 10.1016/j.braindev.2006.04.010

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  8 in total

1.  The course of awake breathing disturbances across the lifespan in Rett syndrome.

Authors:  Daniel C Tarquinio; Wei Hou; Jeffrey L Neul; Gamze Kilic Berkmen; Jana Drummond; Elizabeth Aronoff; Jennifer Harris; Jane B Lane; Walter E Kaufmann; Kathleen J Motil; Daniel G Glaze; Steven A Skinner; Alan K Percy
Journal:  Brain Dev       Date:  2018-04-12       Impact factor: 1.961

2.  Rett Syndrome.

Authors:  E E J Smeets; K Pelc; B Dan
Journal:  Mol Syndromol       Date:  2012-04-16

3.  Respiratory phenotypes are distinctly affected in mice with common Rett syndrome mutations MeCP2 T158A and R168X.

Authors:  J M Bissonnette; L R Schaevitz; S J Knopp; Z Zhou
Journal:  Neuroscience       Date:  2014-03-10       Impact factor: 3.590

4.  Increasing brain serotonin corrects CO2 chemosensitivity in methyl-CpG-binding protein 2 (Mecp2)-deficient mice.

Authors:  Marie A Toward; Ana P Abdala; Sharon J Knopp; Julian F R Paton; John M Bissonnette
Journal:  Exp Physiol       Date:  2012-11-23       Impact factor: 2.969

5.  Impaired CO2 sensitivity of astrocytes in a mouse model of Rett syndrome.

Authors:  Egor Turovsky; Anastassios Karagiannis; Ana Paula Abdala; Alexander V Gourine
Journal:  J Physiol       Date:  2015-06-17       Impact factor: 5.182

6.  Neurophysiology versus clinical genetics in Rett syndrome: A multicenter study.

Authors:  Nicky Halbach; Eric E Smeets; Peter Julu; Ingegerd Witt-Engerström; Giorgio Pini; Stefania Bigoni; Stig Hansen; Flora Apartopoulos; Robert Delamont; Kees van Roozendaal; Maria F Scusa; Paolo Borelli; Math Candel; Leopold Curfs
Journal:  Am J Med Genet A       Date:  2016-06-29       Impact factor: 2.802

7.  Autonomic breathing abnormalities in Rett syndrome: caregiver perspectives in an international database study.

Authors:  Jessica Mackay; Jenny Downs; Kingsley Wong; Jane Heyworth; Amy Epstein; Helen Leonard
Journal:  J Neurodev Disord       Date:  2017-04-28       Impact factor: 4.025

8.  Pinpointing brainstem mechanisms responsible for autonomic dysfunction in Rett syndrome: therapeutic perspectives for 5-HT1A agonists.

Authors:  Ana P Abdala; John M Bissonnette; Adrian Newman-Tancredi
Journal:  Front Physiol       Date:  2014-05-30       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.